FDA Inspection 1217394 — Howard S. Hochster, M.D.

Howard S. Hochster, M.D. — FEI 3003517015

The FDA completed an inspection of Howard S. Hochster, M.D. on Aug 18, 2023 in New Brunswick, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Aug 18, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New Brunswick, NJ (United States)

Additional details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.